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Background: Saccharopolyspora erythraea was extensively utilized for the industrial-scale production of erythromycin A
(Er-A), a macrolide antibiotic commonly used in human medicine. Yet, S. erythraea lacks regulatory genes in the
erythromycin biosynthetic gene (ery) cluster, hampering efforts to enhance Er-A production via the engineering of
regulatory genes.
Results: By the chromosome gene inactivation technique based on homologous recombination with linearized DNA
fragments, we have inactivated a number of candidate TetR family transcriptional regulators (TFRs) and identified one
TFR (SACE_7301) positively controlling erythromycin biosynthesis in S. erythraea A226. qRT-PCR and EMSA analyses
demonstrated that SACE_7301 activated the transcription of erythromycin biosynthetic gene eryAI and the resistance
gene ermE by interacting with their promoter regions with low affinities, similar to BldD (SACE_2077) previously
identified to regulate erythromycin biosynthesis and morphological differentiation. Therefore, we designed a strategy
for overexpressing SACE_7301 with 1 to 3 extra copies under the control of PermE* in A226. Following up-regulated
transcriptional expression of SACE_7301, eryAI and ermE, the SACE_7301-overexpressed strains all increased Er-A
production over A226 proportional to the number of copies. Likewise, when SACE_7301 was overexpressed in an
industrial S. erythraea WB strain, Er-A yields of the mutants WB/7301, WB/2×7301 and WB/3×7301 were respectively
increased by 17%, 29% and 42% relative to that of WB. In a 5 L fermentor, Er-A accumulation increased to 4,230 mg/L
with the highest-yield strain WB/3×7301, an approximately 27% production improvement over WB (3,322 mg/L).
Conclusions: We have identified and characterized a TFR, SACE_7301, in S. erythraea that positively regulated
erythromycin biosynthesis, and overexpression of SACE_7301 in wild-type and industrial S. erythraea strains enhanced
Er-A yields. This study markedly improves our understanding of the unusual regulatory mechanism of erythromycin
biosynthesis, and provides a novel strategy towards Er-A overproduction by engineering transcriptional regulators
of S. erythraea.
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Saccharopolyspora erythraea, a Gram-positive industrial
actinomycetes, produces a valuable macrolide antibiotic
erythromycin A (Er-A). Er-A and its semi-synthetic deriv-
atives, such as clarithromycin, azithromycin, dirithromy-
cin, roxithromycin, and telithromycin, are widely used in
medicine to treat infections caused by pathogenic Gram-
positive bacteria [1]. Considering its high industrial and
medical importance, enhancement of Er-A production
has been performed by metabolic engineering or classical
mutagenesis methods over the past 60 years [2-4]. Also,
as a model actinomycete system, S. erythraea has been
used for studying the biosynthesis and combinatorial bio-
synthesis of polyketide antibiotics, which are synthesized
by modular type I polyketide synthase (PKS) [5,6]. The
erythromycin biosynthetic pathway has been investigated
by genetic and biochemical approaches [7,8]. The erythro-
mycin biosynthetic gene (ery) cluster contains 20 genes
arranged in four major polycistronic units, spanning over
60 kb of DNA [9]. Unusually, the ery cluster lacks any
regulatory genes in S. erythraea, hampering efforts to im-
prove Er-A production by modulating gene regulation
pathways.
Based on a DNA microarray strategy, the industrial
overproducer strain was found to express the entire ery
cluster several days longer than the wild-type strain, sug-
gesting that there exist some regulators for controlling
erythromycin biosynthesis [10]. In vitro and in vivo ap-
proaches led to the identification of BldD (SACE_2077),
a key developmental regulator in actinomycetes [11],
controlling erythromycin biosynthesis and morpho-
logical differentiation in S. erythraea [12]. BldD was
found to bind to the promoter regions of ery cluster.
However, the action of BldD on the promoters of ery
genes was much weaker than on its own promoter [12].
Recently, a putative regulatory protein, SACE_5599, was
proved to positively control erythromycin production
and morphological differentiation in S. erythraea [13].
Nevertheless, the knowledge of molecular regulatory
mechanisms controlling erythromycin biosynthesis re-
mains limited.
The TetR family transcriptional regulators (TFRs),
containing an N-terminal HTH DNA-binding motif and
a C-terminal ligand recognition domain, are widely dis-
tributed in bacteria, playing important roles in antibiotic
biosynthesis, efflux pumps, osmotic stress, and other
functions [14]. TFRs regulate the biosynthesis of mul-
tiple antibiotics or morphogenesis of actinomycetes
[15-28], suggesting that certain TRFs from S. erythraea
are candidates for a role in erythromycin biosynthesis.
With the availability of the complete genome sequence,
101 putative TFRs in S. erythraea were inferred [29].
Based on the homologous recombination with linearized
DNA fragments to inactivate specific genes, a number ofthe S. erythraea TFRs were examined, resulting in the
identification of two TFRs (SACE_7040 and SACE_0012)
having an association with morphological differentiation
[30,31], and one TFR (SACE_3986) negatively control-
ling the erythromycin biosynthesis [32]. Nevertheless,
functions of most TFRs in S. erythraea remain to be
elucidated.
In this study, we identified and characterized a novel
TFR (SACE_7301) that positively regulated erythromycin
biosynthesis. SACE_7301 was found to increase the tran-
scription of erythromycin biosynthetic gene eryAI and the
resistance gene ermE by binding to their promoter regions
in S. erythraea. Further overexpression of SACE_7301 led
to enhanced Er-A titers in the wild-type S. erythraea A226
and the high-yield industrial strain WB.
Results
SACE_7301 positively regulates the erythromycin
biosynthesis
Since extensive investigations have proved that TFRs are
involved in the antibiotic biosynthesis in actinomycetes
through gene inactivation and bioassay experiments [33],
we have identified several TFRs pertinent to erythromycin
production in S. erythraea, including the repressor
SACE_3986 [32], and the activator SACE_7301 currently
studied. By homologous recombination of linearized frag-
ments (Figure 1A), SACE_7301 was replaced by the thios-
trepton resistance gene (tsr) in S. erythraea A226, and the
desired mutant, named as ΔSACE_7301, was isolated and
confirmed by PCR analysis (Figure 1B).
Erythromycin titers of A226 and ΔSACE_7301 were esti-
mated by fermentation and bioassay. ΔSACE_7301 dis-
played lower inhibitory activity against Bacillus subtilis
relative to A226, but had slightly higher levels than the
bldD deletion mutant (Figure 1C), a previously identified
regulator of erythromycin biosynthesis [12]. Furthermore,
A226 and ΔSACE_7301 were cultivated at 30°C for up to 6
days in the R5 liquid fermentation medium, and the ex-
tracts of those cultures were analyzed by HPLC. Compared
with the parental strain A226, ΔSACE_7301 had a 38% re-
duction in the Er-A yield in 6 day fermentation period
(from 58 mg/L to 36 mg/L). (Figure 1D). However, the two
strains had comparable growth rates and cell densities
(Figure 1E). Thus, SACE_7301 is postulated to positively
regulate erythromycin production in S. erythraea.
In order to exclude the possibility that the decreased
erythromycin production was due to a random mutation in
other chromosome loci of S. erythraea, ΔSACE_7301 was
complemented with a copy of SACE_7301 (pZMW7301).
The Er-A yield of the complemented strain ΔSACE_7301/
pZMW7301 was nearly recovered to the parental level
(Figure 1F). To further substantiate the role of SACE_7301
as an activator for erythromycin production, we intro-
duced pZMW and pZMW7301 into A226, obtaining the
Figure 1 Inactivation of SACE_7301 in S. erythraea A226. (A) Schematic inactivation of SACE_7301 in A226 by linearized fragment homologous
recombination. (B) Confirmation of the ΔSACE_7301 mutant by PCR analysis using the primers 7301-P1 and 7301-P4. Lanes: M, 5000-bp DNA ladder.
The size of 3,660 bp for a PCR-amplified band was detected in A226, while the bands of the size 4,360 bp were observed in pUCTSR-Δ7301 and
ΔSACE_7301, indicating that SACE_7301 was replaced with tsr. (C) Inhibition tests of A226, ΔSACE_7301 and ΔbldD fermentation broths against B. subtilis
PUB110. (D) Time course of Er-A yield in A226 and ΔSACE_7301 by HPLC analysis; Mean values of at least three replicates were shown, with the
standard deviation indicated by error bars. (E) Growth curves of A226 and ΔSACE_7301. The two strains were cultured in the R5 liquid fermentation
medium, and their dry weights of mycelia (DWM) were measured. (F) Er-A production in A226, ΔSACE_7301, ΔSACE_7301/pZMW7301, A226/pZMW,
and A226/pZMW7301 cultured in R5 liquid fermentation medium for 6 days by HPLC analysis. Mean values of at least three replicates were shown, with
the standard deviation indicated by error bars.
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pressed strain A226/pZMW7301, respectively. As detected
by HPLC analysis, the Er-A yield of A226/pZMW-7301
was 64 mg/L, that was 10% and 14% increased relative to
those of A226 (58 mg/L) and A226/pZMW (56 mg/L) re-
spectively (Figure 1F). Taken together, our results verified
that SACE_7301 acted as a positive regulator controlling
the erythromycin production in S. erythraea.
SACE_7301 is not involved in the morphological
differentiation of S. erythraea
Previously, BldD and SACE_5599 were identified to con-
currently regulate erythromycin biosynthesis and morpho-
logical differentiation in S. erythraea [12,13]. In order to
discern whether SACE_7301 was also associated with the
morphological differentiation, we inoculated A226 and its
derivative mutants on R3M agar medium for observing
sporulation. ΔSACE_7301, ΔSACE_7301/pZMW7301 andA226/pZMW7301 on R3M plates were identical to A226
in the rate of aerial mycelia formation, whereas ΔbldD
showed the defect of aerial hyphae as expected (data not
shown). These results further substantiate that SACE_7301
acts exclusively as a positive regulator for the synthesis of
erythromycin in S. erythraea.
Overexpression of SACE_7301 increases the transcription
of eryAI and ermE
To investigate the effect of SACE_7301 overexpression
on the transcription of ery genes, we chose erythromycin
biosynthetic gene eryAI (encoding polyketide synthase I)
and the resistance gene ermE (encoding rRNA methyl-
transferase) for transcriptional comparison between con-
trol strain A226/pZMW and overexpressed strain A226/
pZMW7301 on the second or fourth day of growth.
When grown for 4 days, A226/pZMW7301 exhibited
2.2- and 1.7- folds transcription increases detected by
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pZMW (Figure 2B). Similar transcriptional levels of
eryAI and ermE were found for the two strains in 2-day
growth (Figure 2A). The data supports the interpretation
that SACE_7301 plays a positive role in the erythro-
mycin biosynthesis by increasing the transcription of
several structural and resistance genes.
SACE_7301 binds to the promoter regions of eryAI and
ermE
TetR family members often regulate the transcription of
target genes by specifically binding to their promoters
[33]. To examine whether SACE_7301 might directly
regulate the transcription of eryAI and ermE, a full-length
SACE_7301 gene was expressed in Escherichia coli BL21
(DE3) using pET22b, and the purified SACE_7301 protein
fused with His tag (Additional file 1: Figure S1) was used
for in vitro binding experiments by EMSA.
6-FAM labeled eryAI and ermE promoter DNA frag-
ments were respectively mixed with purified His6-tagged
SACE_7301. At concentrations equal or greater than 1 μM
of SACE_7301, mobility shifts were evident. Meantime, it
was found that a 50-fold excess of unlabeled probes
markedly competed with labeled probes for binding to
SACE_7301 (Figure 3A-B). As a negative control, a
non-specific DNA, poly dIdC, was used to compete with
the 6-FAM labeled probes, and the shifted bands did not
disappear (Figure 3A-B), confirming that SACE _7301 spe-
cifically bound to the promoter regions of eryAI and ermE.
To evaluate the relative affinity of SACE_7301 to above-
mentioned probes, we expressed recombinant BldD pro-
tein in E. coli BL21 (DE3), and purified it with His6-tag
(Additional file 1: Figure S1). EMSAs showed that the
concentrations of BldD shifting the two promoter probes
of eryAI and ermE were similar to that of SACE_7301
(Figure 3C-D), indicating that SACE_7301 and BldD had the
same degree of affinities to the two promoters. Therefore,
the combined data indicates that SACE_7301 up-regulatesFigure 2 Effects of SACE_7301 overexpression on transcriptional level
transcripts produced by A226/pZMW, and A226/pZMW7301 cultured in R5
three replicates were shown, with the standard deviation indicated by errothe transcription of eryAI and ermE by directly interacting
with their promoter regions.
Effects of SACE_7301 overexpression on erythromycin
biosynthesis in S. erythraea A226
As overexpression of SACE_7301 with an extra copy dis-
played an increase of Er-A production in S. erythraea
A226 as described above, we proposed that increased
copy numbers of SACE_7301 would lead to additional
increases in Er-A levels. SACE_7301 under the control
of PermE* was cloned into pSET152, creating 1, 2, or 3
copies of SACE_7301, introduced into A226 (Figure 4A),
to generate A226/7301, A226/2×7301 and A226/3×7301
strains respectively. By fermentation and HPLC analysis,
the three strains all presented Er-A product improve-
ment (Figure 4B). Furthermore, the Er-A production ex-
hibited a positive correlation with the copy number of
SACE_7301, reaching the highest 1.44 folds with 3 cop-
ies (Figure 4B). When cultured in the R5 liquid medium,
these strains had comparable growth rates and cell dens-
ities (Additional file 1: Figure S2), suggesting that the en-
hanced erythromycin yield in SACE_7301-overexpressed
strains was not caused by the increase of biomass.
In addition, qRT-PCR was used to compare the tran-
scriptional levels of SACE_7301, eryAI and ermE be-
tween A226 and its SACE_7301-overexpressed strains.
With the increase of SACE_7301 copy number, the tran-
scripts of SACE_7301 in A226/7301, A226/2×7301 and
A226/3×7301 were found to be up-regulated by 4.6-,
8.4- and 16.5-folds relative to that of A226 (Figure 4C).
Likewise, the transcripts of eryAI and ermE in those mu-
tants were gradually increased compared to the original
level (Figure 4C). These results indicated that overex-
pression of SACE_7301 with 1 to 3 extra copies in S. ery-
thraea associated with a stepwise increase of Er-A
production by promoting the transcription of eryAI and
ermE. In conjunction with RNA changes, A226/3×7301
also demonstrated increased resistance to erythromycins of eryAI and ermE. qRT-PCR was used to quantify the amounts of
fermentation medium for 2 (A) or 4 days (B). Mean values of at least
r bars.
Figure 3 Electrophoretic mobility shift assays (EMSAs) with the promoter regions of eryAI or ermE and purified His6-tagged SACE_7301
or His6-tagged BldD. (A) EMSAs with recombinant SACE_7301 protein and PeryAI. (B) EMSAs with recombinant SACE_7301 protein and PermE.
(C) EMSAs with recombinant BldD protein and PeryAI. (D) EMSAs with recombinant BldD protein and PermE. Each of the lanes contained 10 ng
DNA. Results were one representative example of at least three replicates.
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greater than 160 μg/ml erythromycin (Additional file 1:
Figure S3).
Also, we cultured A226/3×7301 in the R5 liquid medium
for 6 days without addition of apramycin, and found that
the size of the gene expression cassette containing the 3
copies of SACE_7301 from plasmid pSET152-3×7301 did
not change by PCR analysis (Additional file 1: Figure S4),
indicating that the engineered strain had a stably inserted
SACE_7301.
Improved Er-A production by overexpression of
SACE_7301 in an industrial strain WB
To examine the applicability of overexpression of
SACE_7301 for enhancing erythromycin production in
industrially-relevant strains, SACE_7301 was introduced
into an industrial S. erythraea WB strain with 1, 2 or 3
extra copies under the control of PermE*, and the de-
sired mutants WB/7301, WB/2×7301 and WB/3×7301
were obtained. In flask experiments with an industrial
medium for 6 days, the Er-A yields of WB/7301 (685
mg/L), WB/2×7301 (755 mg/L) and WB/3×7301 (832
mg/L) were respectively increased by 17%, 29%, and 42%
in comparison to that of WB (586 mg/L) (Figure 5A).
Likewise, no significant change of cell growth was de-
tected for these strains in comparison (Additional file 1:
Figure S2).
We also tested the reproducibility of one of the engi-
neered strains in a larger scale by selecting the highest-
yield strain WB/3×7301. Following 8-day fermentationat a 5 L fermentor scale, WB/3×7301 exhibited a strikingly
higher Er-A yield (4,230 mg/L), that was 27% greater than
WB (3,322 mg/L). Since this strain maintains the charac-
teristics of its parental strain, we conclude that the add-
itional Er-A production from SACE_7301-engineered
industrial strains will be of significant commercial value.
Discussion
TFRs form homodimers that generally act as transcrip-
tional repressors to regulate the transcription of genes
involved in antibiotic biosynthesis or resistance [34], but
little is known about the TFR as a positive regulator for
controlling the antibiotic biosynthesis in actinomycetes.
Recently, the TetR family regulatory gene gouR, situated
in the gene cluster of gougerotin biosynthesis, was char-
acterized to be a positive regulator for modulating the
gougerotin production by coordinating its biosynthesis
and export in Streptomyces graminearus [27]. In this
work, we identified a novel TFR (SACE_7301) from S.
erythraea, and proved that it played a positive role in
regulating erythromycin biosynthesis.
SACE_7301 was shown to specifically bind to the pro-
moter regions of eryAI and ermE in vitro, and enhance
their transcription. SACE_7301, located approximately
8.1 Mb in the chromosome of S. erythraea, is not closely
positioned with the ery cluster (GenBank Accession No.
NC-009142. 778,214–832,825 nt, 0.8 Mb) and therefore
it became evident that the gene product of SACE_7301
might function as a trans-acting factor remotely regulat-
ing erythromycin biosynthesis. This regulation pattern
Figure 5 Overexpression of SACE_7301 in the industrial strain S. erythraea WB resulted in a higher Er-A production. (A) Er-A yield of WB
and its derivatives cultured in flasks for 6 days. Mean values of at least three replicates were shown, with the standard deviation indicated by error
bars. (B) Time course of Er-A production of WB and WB/3×7301 in a 5 L fermentor. One of the representative datasets was shown.
Figure 4 Effects of overexpression of SACE_7301 on erythromycin biosynthesis in S. erythraea A226. (A) Schematic illustration of the
strategy for construction of expression plasmids with 1 to 3 copies of SACE_7301. (B) Er-A production of A226 and SACE_7301-overexpressed
mutants. (C) qRT-PCR analyses of gene transcription in A226 and SACE_7301-overexpressed mutants. Mean values of at least three replicates were
shown, with the standard deviation indicated by error bars.
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lator for erythromycin biosynthesis [12]. As SACE_7301 ex-
hibited low affinities to eryA and ermE promoters, it was
difficult to determine the tight binding sites through DNase
I footprinting assay. On the other hand, moderate increase
in Er-A production was achieved by overexpression of
SACE_7301 with an extra copy, similar to BldD in S. ery-
thraea A226 [35]. These data indicate that SACE_7301 is
likely a positive regulator that directly acts on the pro-
moters of ery genes.
Through phylogenetic analysis [34], SACE_7301 ho-
mologs are distributed in rare actinomycetes, such as
KUTG_05296 from Kutzneria sp. 744 (62% identity),
Amir_6979 from Actinosynnema mirum ATCC29888 (63%
identity), BN6_83740 from Saccharothrix espanaensis
ATCC51144 (60% identity) (Additional file 1: Figure S5).
However, since none of these TFRs has been uncovered in
actinomycetes, it potentially signifies a novel regulatory
mechanism in actinomycetes, such as how it functions with
its ligand [36].
To further improve the production of erythromycin,
an overexpression tactic was designed and utilized for
overexpressing SACE_7301 under PermE* in wild-type
strain A226 and industrial overproducer WB. Along with
the increase of SACE_7301 copy number, SACE_7301,
eryAI and ermE were significantly up-regulated, and Er-
A yields of those mutants rose step by step. However,
these changes in transcription level do not linearly cor-
respond to the changes in Er-A production. A similar re-
sult was also reported for the TetR family regulator
GouR in S. graminearus [27].
Overexpression of bldD or SACE_5599 could improve
erythromycin production in the wild-type S. erythraea
strain, but not in the industrial overproducer [13]. Consid-
ering that WB is already an industrial strain, it is likely that
overexpression of SACE_7301 will have commercial value
when applied in other erythromycin high-yield S. erythraea
strains. In other examples, the overexpression approach
was utilized to engineer the halogenase gene ctcP, resulting
in improvement of chlortetracycline production in indus-
trial S. aureofaciens [37]. Overexpression of tailor genes
eryK and eryG was also performed to enhance the produc-
tion and purity of Er-A in an industrial S. erythraea [4]. To
our knowledge, this is the first report for tandemly express-
ing transcriptional regulators to enhance antibiotic produc-
tion in actinomycetes. We anticipate that the strategy of
overexpression of additional regulators will be generally ap-
plicable for improvement of other antibiotics in industry.
Conclusion
The novel TFR SACE_7301 positively regulates erythro-
mycin biosynthesis in S. erythraea, and it activated the tran-
scription of erythromycin biosynthetic gene eryAI and the
resistance gene ermE by interacting with their promoters.Furthermore, when SACE_7301 was overexpressed in wild-
type or industrial S. erythraea strains with 1 to 3 extra cop-
ies, Er-A yields had stepwise enhancement in comparison
to the parental strains. Our data here form a new under-
standing of the unusual regulatory mechanism of ery-
thromycin biosynthesis, and provide a valuable means to
improve erythromycin production.
Materials and methods
Strains, plasmids, and culture conditions
All strains and plasmids used in this study are listed in
Table 1. S. erythraea and its derivatives were grown either
in TSB liquid medium for seed culture, DNA extraction
and protoplast preparation, or on R3M agar medium for
protoplast regeneration or phenotypic observation with
thiostrepton or apramycin when appropriate [38,39]. E. coli
and B. subtilis strains were cultured in Luria-Bertani (LB)
liquid medium or on LB plates at 37°C [40]. The general
techniques in E. coli and S. erythraea were performed
as described [38,40].
Gene inactivation, complementation and overexpression
of SACE_7301
With S. erythraea A226 genomic DNA as a template, two
1.5-kb DNA fragments flanking the SACE_7301 gene were
amplified by PCR using the primer pairs 7301-P1/7301-P2
and 7301-P3/7301-P4 (Table 2). The two PCR products
were respectively digested with EcoRI/KpnI and XbaI/
HindIII, and ligated into the corresponding sites of
pUCTSR [30], obtaining pUCTSR-Δ7301. By the homolo-
gous recombination with linearized fragments [41], the
SACE_7301 gene of S. erythraea A226 was replaced with
the thiostrepton resistance gene (tsr). The desired
thiostrepton-resistant mutant, named ΔSACE_7301, was
further confirmed by PCR analysis using the primers
7301-P1/7301-P4 (Table 2).
Using the primers 7301-P5 and 7301-P6 (Table 2), a 0.66-
kb DNA fragment containing a full-length SACE_7301 was
amplified by PCR with the genomic DNA of A226 as a tem-
plate. The PCR product was cleaved with NdeI/EcoRV, and
inserted into the corresponding sites of integrative plasmid
pZMW [42], yielding pZMW-7301. By PEG-mediated
protoplast transformation, pZMW7301 was introduced into
the ΔSACE_7301 mutant and the parental strain A226,
respectively. The complemented strain ΔSACE_7301/
pZMW7301 and overexpression strain A226/pZMW7301
were obtained by apramycin resistance screening and con-
firmed by PCR analysis with the primers apr-F and apr-R
(Table 2).
Overexpression of SACE_7301 in S. erythraea
In order to introduce 1 to 3 extra copies of SACE_7301
into the chromosome of S. erythraea, the combined
DNA fragment containing PermE* and SACE_7301 from









ΔSACE_7301 A226 with SACE_7301 deleted This study
ΔSACE_7301/
pZMW






A226/pZMW A226 carrying pZMW This study
A226/pZMW7301 A226 carrying pZMW7301 This study
A226/7301 A226 carrying pSET152-7301 This study
A226/2×7301 A226 carrying pSET152-2×7301 This study
A226/3×7301 A226 carrying pSET152-3×7301 This study





WB/7301 WB carrying pSET152-7301 This study
WB/2×7301 WB carrying pSET152-2×7301 This study
WB/3×7301 WB carrying pSET152-3×7301 This study
E. coli
DH5α F recA lacZM15 [40]




pUCTSR pUC18 derivative containing a
1.36-kb fragment of a
thiostrepton resistance cassette
in the BamHI/SmaI sites
[41]
pUCTSR-Δ7301 pUCTSR carrying two 1.5-kb
fragments of the flanking
sequence of SACE_7301 gene
This study
pZMW E. coli-S. erythraea integrative
shuttle vector carrying PermE*
[42]
pZMW7301 pZMW carrying SACE_7301 This study
pBluescript II
SK (+)
bla, lacZ orif1 Stratagene
pSK-7301 pBluescript II SK (+) carrying
SACE_7301 under the control
of PermE*
This study
pSET152 E. coli-S. erythraea integrative
shuttle vector
[43]
pSET152-7301 pSET152 carrying SACE_7301
under the control of PermE*
This study
pSET152-2×7301 pSET152 carrying two extra
copies of SACE_7301 under the
control of PermE*
This study
pSET152-3×7301 pSET152 carrying three extra
copies of SACE_7301 under the
control of PermE*
This study
pET22b T7 promoter, His-tag, kan Novagen
pET22b-7301 pET22b carrying SACE_7301 This study
pET22b-bldD pET22b carrying bldD This study
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primer pair ermE-F and 7301-R (Table 2). The ampli-
fied product was cloned into pBluescript II SK (+) via
XbaI and SpeI sites (Figure 4A), and the correct
sequence was confirmed by DNA sequencing. The
fragment digested with XbaI and SpeI was repeatedly
subcloned into XbaI site of pSET152 to generate
pSET152-7301, pSET152-2×7301 and pSET152-3×7301,
respectively (Figure 4A). Those plasmids were succes-
sively introduced into S. erythraea A226 or WB,
and corresponding SACE_7301-overexpressed strains
were obtained by apramycin screening and PCR
confirmation.Fermentation and erythromycin assay
For flask fermentation of A226 and its derivatives, spores
from R3M plates cultured for 4 days were incubated in
250 ml baffled flasks containing 30 ml TSB medium for
2 days at 30°C. Then, 3 ml cultures were inoculated into
250 ml baffled flasks containing 30 ml R5 liquid fermenta-
tion medium [38], and shaken for 6 days at 30°C (220 rpm).
For flask fermentation of the erythromycin high-yielding
strain WB and its derivatives, a liquid industrial
medium was used as previously described [32]. After
24 h fermentation, 0.3 ml of n-propanol was added into
the cultures and further incubated for 5 days at 30°C
(220 rpm).
For bioreactor cultures of WB and its SACE_7301-over-
expressed strain WB/3×7301, the fermentation experiments
were carried out in a 5 L fermentor (Baoxing, Shanghai,
China) containing 3 L liquid industrial medium. Seed cul-
tures for the cultivation in bioreactors were prepared as de-
scribed above, using 450 ml industrial seed medium in 2 L
baffled flasks. Bioreactors were inoculated with 30 vol.%
seed culture. Dissolved oxygen concentration and pH
were monitored using autoclavable electrodes (Mettler
Toledo, Switzerland). Dissolved oxygen was maintained
about 50% with increasing agitation and aeration rate
during the bioprocess, and the pH was kept at 7.0 to
7.2. Foaming was controlled by automatic addition of
antifoam. Samples (50 ml) were taken every 24 h for
Er-A yield analysis with HPLC as described previously
[44]. HPLC analysis was performed on Agilent 1260
HPLC system equipped with an Agilent Extend-C18
column (5 μm, 250 × 4.6 mm), which was equilibrated
with 40% solution A (acetonitrile, chromatographic
grade) and 60% solution B (potassium dihydrogen phos-
phate, 0.032 mol/L, pH 6.8). An isocratic program was
carried out at a flow rate of 1.0 ml/min at 29°C using
UV detector at 210 nm.
For bioassay-based analysis, A226, ΔSACE_7301 and
ΔbldD were grown in 30 ml R5 liquid medium in
250 ml flasks for 6 days at 30°C. 5 μl fermentation
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LB agar plates, which were sprayed with an overnight
culture of B. subtilis PUB110. The plates were incubated
at 37°C for 12 h, and the erythromycin production was
estimated by detecting the growth-inhibition zones as
previously demonstrated [31]. Moreover, Er-A produced
by A226, WB and their derivatives were quantitatively
analyzed by HPLC.
Transcriptional analysis by quantitative real-time PCR
(qRT-PCR)
The relative transcriptional levels of eryAI and ermE, from
erythromycin biosynthetic gene cluster [7], were deter-
mined by qRT-PCR analysis. Specific primers were designed
as listed in Table 2. According to the manufacturer’s in-
structions of a RNA extraction/purification kit (SBS), totalTable 2 Primers used in this study
Name Sequence (5′-3′) (restriction site with italic form
7301-P1 CGCGAATTCGCATCCTCG AGCACTTCACCG (EcoRI)
7301-P2 CCCGGTACCCGGCTCCGGATGGAACCG (KpnI)
7301-P3 CTCTCTAGACACCACGGCGGCCTGCCG GC (XbaI)
7301-P4 CCAAAGCTTGGAGTCGGCGCATGCTGGTCTC (HindII
7301-P5 AGACATATGATGAAGGCCGACGTGGAGCAC (NdeI)























Test-R GAATTCGATATCGCGCGCGGCCGCGGATCCRNA was extracted from S. erythraea A226 and its deriva-
tives after 2 or 4 days of growth on R5 agar medium [38].
Isolated RNA was treated with DNase I (MBI Fermentas),
and reverse transcription was achieved using a cDNA
synthesis kit (MBI Fermentas). Quantitative real time PCR
reactions were performed on the Applied Biosystems
Step-One Plus system with Maxima™ SYBR Green/ROX
qPCR Master Mix (MBI Fermentas). The hrdB gene
encoding the major sigma factor in S. erythraea was
used as an internal control, and relative quantification
was evaluated using a comparative cycle threshold (CT)
method [45].
Overexpression and purification of SACE_7301 and BldD
As the original SACE_7301 gene could not be expressed in





qRT-PCR analysis of SACE_7301
GTCC Expression of SACE_7301 In E. coli
NdeI) Expression of BldD In E. coli
Cloning of combined DNA fragment containing
PermE* and SACE_7301
qRT-PCR analysis of eryAI
EMSA of eryAI promoter
qRT-PCR analysis of ermE
EMSA of ermE promoter
qRT-PCR analysis of hrdB as internal reference
PCR analysis of the cassette containing 3 copies
of PermE*-SACE_7301
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primers 7301-P9 and 7301-P10 (Table 2). The PCR product
was cloned into NdeI and HindIII restriction sites of
pET22b to generate pET22b-7301. Then, pET22b-7301
was introduced into E. coli BL21 (DE3) for protein pro-
duction. Gene expression was induced with 1 mM iso-
propylthiogalactoside (IPTG) for 5 h at 30°C. Cells were
harvested and followed by sonication treatment. Purifica-
tion of His6-tagged protein was carried out by use of
Ni-NTA Sepharose chromatography [46]. The concentra-
tion of purified protein was quantified by BCA assays, and
its purity was judged by sodium dodecyl sulfate polyacryl-
amide gel electrophoresis (SDS-PAGE) analysis. Similarly,
bldD was amplified with the primers bldD-F and bldD-R
(Table 2), and expressed in E. coli BL21 (DE3).
Electrophoretic mobility shift assays (EMSAs)
EMSAs were carried out in the light of previously de-
scribed methods [47]. Using the genomic DNA from S.
erythraea A226 as a template, the promoter regions of
eryAI and ermE were successively amplified by PCR with
their respective primers (Table 2) labeled at 5′ end by the
6-isomer of carboxyfluorescein (6-FAM). Those labeled
DNA fragments were independently mixed with purified
His6-tagged SACE_7301 or BldD proteins. The binding re-
action system consisted of 10 mM Tris (pH 7.5), 5 mM
MgCl2, 50 mM EDTA, 60 mM KCl, 10 mM DTT, 10% gly-
cerol, 150 ng labeled probes and 0.5-4 μM purified
SACE_7301 or BldD. For competitive inhibition of the
binding reaction, 7.5 μg unlabeled above-mentioned DNA
fragments or 7.5 μg poly dIdC were added into that reac-
tion system, respectively. After incubation on ice for
10 min, the reactants were run on an 8% TBE polyacryl-
amide gel (Bio-Rad) with 0.5 × TBE as a running buffer at
30 mA for 1 h.
Additional file
Additional file 1: Figure S1. Purification of His6-tagged SACE _7301 and
BldD. Left lane 116 KDa protein ladder. Figure S2. Time courses of dry
weight of mycelia (DWM) of low-yielding S. erythraea strain A226, industrial
overproducer WB, and their derivatives. Mean values of at least three
replicates were shown, with the standard deviation indicated by error bars.
Figure S3. Growth of A226 and A226/3×7301 treated with erythromycin.
The two strains were cultured in the R5 liquid medium for 2 days by
addition of four concentrations of erythromycin (40 μg/ml, 80 μg/ml, 160
μg/ml and 320 μg/ml), respectively, and their dry weights of mycelia (DWM)
were successively measured. Mean values of at least three replicates were
shown, with the standard deviation indicated by error bars. Figure S4. PCR
analysis of the cassette containing 3 copies of PermE*-SACE_7301 from
A226/3×7301 using the primers Test-F and Test-R. The specific primers
flanking above-mentioned cassette of the plasmid pSET152-3×7301 were
designed as shown in Table 2. A226/3×7301 was cultured in the R5 liquid
medium for 6 days without apramycin. Lanes: M: 5, 000-bp DNA ladder, +:
positive control (pSET152-3×7301 as a template), -: negative control
(Genomic DNA of A226 as a template), 1 to 6: Genomic DNA of A226/
3×7301 cultured for 1 to 6 days, respectively, 7: Genomic DNA of the
mixture of A226/7301, A226/2×7301 and A226/3×7301 with equal amount.Figure S5. Phylogenetic tree of SACE_7301 homologs by the neighbor-
joining method. The number at each node indicates the percentage of 1000
bootstrap replications.
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